NLRP3 and neoplasm: IL-6 enhances immune cell recruitment and promotes tumor progression by inducing epithelial-to-mesenchymal transition (EMT) and angiogenesis [66], while IL-1β and IL-18 are key pro-inflammatory cytokines activated by the NLRP3 inflammasome pathway.